Wise move to invest your truckloads of ALA-profits here. ALA got no clinical trial but a MC above AUD 100m while CHM got " hundreds " of clinical trials and a MC close to ZERO.
The ASX sometimes makes you questioning if all those valuations make sense.
GLTA
Ann: Chimeric to present at NWR Virtual Healthcare Conference, page-11
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.67M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| CHM (ASX) Chart |
Day chart unavailable